Research Grade Trontinemab (DHC12508);Trontinemab;Research Grade Trontinemab
用途
Trontinemab is used for targeting amyloid-beta (Aβ) plaques and transferrin receptor 1 (TFR1) to facilitate clearance of Aβ plaques in the brain, leveraging its brain-penetrant, anti-amyloid, bispecific, and humanized IgG1-κ antibody properties; it binds fibrillar Aβ and Aβ plaques and engages immune cells in the Alzheimer's disease (AD) brain to trigger plaque clearance.